{"created":"2022-02-22T07:17:45.305661+00:00","id":2016871,"links":{},"metadata":{"_buckets":{"deposit":"93b8a000-9ae3-4961-8bfc-d1553c62181e"},"_deposit":{"id":"2016871","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"2016871"},"status":"published"},"_oai":{"id":"oai:u-ryukyu.repo.nii.ac.jp:02016871","sets":["1642838163960:1642838198944:1642838199408:1642838229560","1642838403551:1642838412624"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"[原著]Increased plasma tacrolimus concentration after single intravenous administration of voriconazole : a case of drug–drug interaction","subitem_title_language":"ja"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Shiohira, Hideo","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yamada, Satoshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Uehara, Hitoshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Hokama, Nobuo","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ueda, Shinichiro","creatorNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"tacrolimus","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"voriconazole","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"CYP3A4/5","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"drug–drug interaction","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"therapeutic drug monitoring","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"Tacrolimus, as one of cytochrome P450 (CYP) 4/5 substrates is known to have many drug–drug interactions. Metabolism of tacrolimus is inhibited by many drugs, such as the azole antifungal agents due to their effects on CYP 3A4/5. Implementation of therapeutic drug monitoring is commended during tacrolimus treatment for maintaining optimal plasma concentration levels, and to avoid its toxicity. We herein report a case of a 58-year-old female patient with lupus nephritis whose plasma concentration of orally ministered tacrolimus increased after a single administration of 300 mg voriconazole for suspected Aspergillus infection. Our observations were the result of therapeutic drug monitoring before the second administration of voriconazole. Although tacrolimus dose did not vary, the plasma tacrolimus concentration was markedly increased and concentration dose ratio was 2.1 fold more than prior to voriconazole treatment. This case suggests that even after a single intravenous administration of voriconazole, the plasma concentration of tacrolimus may increase. Dose optimization of tacrolimus by therapeutic drug monitoring soon after the first dose of voriconazole is therefore warranted to minimize the risk of tacrolimus toxicity.","subitem_description_type":"Other"},{"subitem_description":"論文","subitem_description_type":"Other"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"琉球医学会","subitem_publisher_language":"ja"},{"subitem_publisher":"Ryukyu Medical Association","subitem_publisher_language":"en"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_source_identifier":"1346-888X","subitem_source_identifier_type":"ISSN"},{"subitem_source_identifier":"AN10369445","subitem_source_identifier_type":"NCID"}]},"item_1617186941041":{"attribute_name":"Source Title","attribute_value_mlt":[{"subitem_source_title":"琉球医学会誌 = Ryukyu Medical Journal","subitem_source_title_language":"ja"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueNumber":"1-3","bibliographicPageEnd":"44","bibliographicPageStart":"41","bibliographicVolumeNumber":"33"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","filename":"v33(1-3)p41.pdf","mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://u-ryukyu.repo.nii.ac.jp/record/2016871/files/v33(1-3)p41.pdf"},"version_id":"9732b9df-4bfa-4a73-a1aa-cafc31570839"}]},"item_title":"[原著]Increased plasma tacrolimus concentration after single intravenous administration of voriconazole : a case of drug–drug interaction","item_type_id":"15","owner":"1","path":["1642838229560","1642838412624"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2015-12-28"},"publish_date":"2015-12-28","publish_status":"0","recid":"2016871","relation_version_is_last":true,"title":["[原著]Increased plasma tacrolimus concentration after single intravenous administration of voriconazole : a case of drug–drug interaction"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2022-02-22T07:17:50.626362+00:00"}